论文部分内容阅读
选取2012年1月~2014年4月我院收治的200例急性出血性胃炎患者。随机分为研究组和对照组各100例。对照组给予常规内科治疗,研究组在对照组基础上给予奥美拉唑联合硫糖铝治疗,随访3个月,综合比较两组患者治疗总有效率、住院时间、复发率和不良反应发生率。结果研究组治疗总有效率为96.0%,高于对照组的83.0%(P<0.05);研究组住院时间、复发率,均少于对照组(P<0.05);两组患者均无严重不良反应发生(P>0.05)。奥美拉唑联合硫糖铝治疗急性出血性胃炎效果确切,可缩短住院时间,降低复发率,无严重不良反应,值得临床推广使用。
Select from January 2012 to April 2014 in our hospital admitted 200 cases of patients with acute hemorrhagic gastritis. Randomly divided into study group and control group of 100 cases. The control group was given conventional medical treatment. The study group was given omeprazole and sucralfate on the basis of the control group, followed up for 3 months. The total effective rate, length of hospital stay, recurrence rate and incidence of adverse reactions in both groups were compared . Results The total effective rate in study group was 96.0%, which was higher than that in control group (83.0%, P <0.05). The hospitalization time and recurrence rate in study group were less than those in control group (P <0.05) The reaction occurred (P> 0.05). Omeprazole combined with sucralfate in the treatment of acute hemorrhagic gastritis exact effect, can shorten the hospital stay, reduce the recurrence rate, no serious adverse reactions, it is worth promoting the use of the clinic.